Pupillometric Assessment of Small Doses of Opioid
in a Pediatric Population
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Background
Opioid prescriptions in the United States have
more than tripled from 1999-2014, during which
there has been a staggering increase in opioidinvolved drug overdose deaths. Providers need
the means to objectively monitor analgesic
efficacy of treatment in patients with pain to
mitigate unnecessary prescriptions.
It is well established that mu opioid receptor
agonists like morphine cause miosis, an effect that
does not exhibit tolerance. This suggests utility in
investigating pupil size and responsiveness as
pharmacokinetic measures of bioavailability. An
infrared pupillometer is a device that produces a
short light stimulus and subsequently measures
parameters of the pupillary light reflex (PLR)
including maximum and minimum pupil size
(MAX, MIN), maximum constriction velocity
(MCV), latency period before constriction onset
(LAT), change in pupil size (DELTA), and average
constriction velocity (ACV).

Discussion

Methods
The Neuroptics PLR-2000 pupillometer was used to assess six pupillary parameters. Fifteen patients
between the ages of 7 and 18 receiving low does opioids on patient controlled analgesia (PCA) were
enrolled from the pain medicine service at Children’s National Medical Center.
Patients were either post-surgical or admitted for sickle cell vaso-occlusive crisis. Baseline PLR
parameters were measured prior to PCA dose. Two subsequent measurements were taken ten and
fifteen minutes post PCA dose (figure 2).

In concordance with previous research, the MIN is
significantly correlated with opioid concentration
dose-dependently across the 15-minute
measurement window. Current data support the
efficacy of using infrared pupillometry to detect
high dose opioid presence, but this research
specifically demonstrates its efficacy in monitoring
low dose therapeutic levels.
Establishing the pupillometer as a pharmacokinetic
analog has many clinical applications. For example,
genetic testing for polymorphisms that play a role
in opioid metabolism (ex CYP2D6, OPRM1) can be
eliminated. More widespread applications include
the continuous monitoring of patients’ opioid
response to minimize unnecessary administration
and to identify tolerance and hyperalgesia.

Figure 2: Pupillary response to a light stimulus was compared before and after PCA administration

Results
A repeated measures ANOVA was conducted to compare the effect of the opioid on specific
parameters of the PLR (GraphPad Prism 7.0c). There was a significant effect of the opioid on the
MAX, MIN, LAT and MCV parameters (Table 1). Dunnett’s test was used to make post hoc
comparisons between each parameter time point and that parameters’ baseline measure. This
test indicated that the 10-minute and 15-minute time points were significantly smaller than the
baseline for the parameters MAX (p=.0016, p=.0010) and MIN (p=.0250, p=.0070). The LAT
parameter was found to be significantly faster from baseline at the 15-minute measure
(p=.0350).
Figure 1: Using a pupillometer

Purpose
The goal of this study was to use infrared
pupillometry to demonstrate the pattern of
changes in PLR parameters before and after
receiving low dose opioid analgesia.

Tukey’s test was used to make comparisons of each time point to one another and
found that there was a significant difference between the 10-minute and 15-minute time points
for the MIN (p=0.0251)
MAX
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F Statistic

11.68
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3.746

2.326

3.414

Hypotheses

p-Value

0.0021*

0.0036*

0.1989

0.0393*

0.1239

0.0490*

1. Patients receiving opioid analgesia will display
differential parameters of their PLR before and after
drug administration.

R2

0.4548

0.4239

0.1125

0.2111

0.7908

0.1961

2. Opioid analgesics have a dose-dependent effect
on parameters of the PLR.

Table 1: Repeated measures ANOVA evaluating the significance
of all pupillary parameters baseline vs. post-PCA dosing.
* P-value < 0.05

Figure 3: PLR of an individual patient on PCA opioid pain
control. Time points show the opioid induced decrease in
pupil diameter and change in pupil response.

Next Steps
• Compare PLR parameters to blood levels of
opioid metabolites to further support the
efficacy of this novel pharmacokinetic measure
• Create an algorithm combining PLR data with
pharmacodynamics--subjective pain scores-- to
determine opioid sensitivity, tolerance, and
hyperalgesia.
• Develop a noninvasive tool to objectively
measure the analgesic effects of opioid
medications.

